Recurrent squamous, basal cell carcinoma of the pharynx,larynx,lip
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Microbiome in Head and Neck Squamous Cell Carcinoma
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Metagenomic sequencing
- Metabolic analysis
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Apr 19, 2023
Laryngeal Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in
Not yet recruiting
- Laryngeal Squamous Cell Carcinoma
- +2 more
- Sentinel lymph node biopsy guided selective elective neck irradiation
- Standard elective neck irradiation
-
Amsterdam, Netherlands
- +5 more
Aug 30, 2022
Complications and Recurrences After Mohs Micrographic Surgery
Recruiting
- Skin Cancer
- +9 more
- Mohs surgery
- Slow Mohs surgery
-
Maastricht, NetherlandsMaastricht University Medical Center+
Aug 23, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Head Neck Cancer Trial in San Diego (Medpulser Electroporation with Bleomycin, Surgical Excision)
Terminated
- Head Neck Cancer
- Medpulser Electroporation with Bleomycin
- Surgical Excision
-
San Diego, CaliforniaInovio Biomedical Corporation
Mar 2, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)
Recruiting
- Lip
- +4 more
- Nivolumab
- +3 more
-
Columbus, Ohio
- +1 more
Oct 25, 2021
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell
Completed
- Stage IV Squamous Cell Carcinoma of the Hypopharynx
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2021
Larynx, Lip, Oral Cancer Trial in Chapel Hill, Charleston (Durvalumab, Intensity Modulated Radiotherapy Treatments)
Active, not recruiting
- Larynx
- +3 more
- Durvalumab
- Intensity Modulated Radiotherapy Treatments
-
Chapel Hill, North Carolina
- +1 more
May 26, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States
Recruiting
- Adenoid Cystic Skin Carcinoma
- +38 more
- Biopsy
- +6 more
-
Los Angeles, California
- +35 more
Jan 31, 2023
Head-and-neck Cancer Trial in Denmark (Proton radiotherapy)
Active, not recruiting
- Head-and-neck Cancer
- Proton radiotherapy
-
Aalborg, Denmark
- +6 more
Jun 15, 2022
Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous
Completed
- Head and Neck Cancer
- +19 more
- lapatinib ditosylate
- capecitabine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Mar 6, 2020
Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- PET/CT
- Neck dissection
- (no location specified)
Jan 31, 2023
Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)
Recruiting
- Squamous Cell Carcinoma
- Head and Neck Cancer
- Intensity-modulated radiotherapy
- Magnetic Resonance Guidance
-
Tampa, FloridaMoffitt Cancer Center
Nov 13, 2023
Following Salvage Surgery for RESidual or reCurrent sqUamous
Not yet recruiting
- Head and Neck Cancer
- Molecular Analyses
- (no location specified)
Mar 28, 2023
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- erlotinib hydrochloride
- +10 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020